Pathologic response evaluation of localized or locally advanced esophageal carcinoma to induction chemotherapy followed by preoperative concurrent chemotherapy and hypofractionated radiotherapy: a clinical trial

ObjectiveEsophageal cancer is a therapeutic challenge in most healthcare systems. Most patients present with locally advanced disease at diagnosis. Concurrent chemoradiotherapy (CRT) is the standard treatment for locally advanced esophageal carcinoma. Since achieving a complete pathological response...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Ali Emadi Torghabeh, Seyed Amir Aledavood, Ehsan Soltani, Mahsa Akbari Oryani, Saeed Akhlaghi, Sare Hosseini, Azar Fani Pakdel, Ali Taghizadeh Kermani, Kazem Anvari, Soodabeh Shahidsales, Shahrzad Bahadorian, Shervin Mashreghi Moghaddam
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	concurrent chemoradiotherapy esophageal cancer hypofractionated radiotherapy induction chemotherapy pathologic response
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1439730/full